AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.
The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.
AC Immune SA is currently in the growth stage of being a clinical-stage biopharmaceutical company. They are pioneering precision medicine for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and rare indications. With a diverse pipeline of clinical and preclinical product candidates, they are addressing the increasing incidence of neurodegenerative diseases on a global scale. Their deep knowledge and cutting-edge technology platforms are driving scientific and clinical advances in the field of neurodegeneration.
AC Immune has achieved significant milestones in its history through strategic partnerships with global pharmaceutical leaders such as Genentech, Janssen Pharmaceuticals, and Eli Lilly and Co. These collaborations validate the company's scientific leadership, technologies, and pipeline. The recent FDA fast track designation for its anti-amyloid-beta active immunotherapy, ACI-24.060, to treat Alzheimer's disease further demonstrates the company's progress in developing breakthrough therapies for neurodegenerative diseases.
AC Immune has been involved in pioneering precision medicine approaches for neurodegenerative diseases, with a focus on developing breakthrough therapies through innovative science. Their broad and diversified pipeline includes diagnostic and therapeutic candidates targeting misfolded proteins underlying these diseases. By integrating different treatment modalities, such as antibodies and small molecule drugs, the company aims to address the complex nature of neurodegeneration and provide personalized solutions for patients.
AC Immune has been actively engaged in key events that showcase the company's growth and impact in the field of neurodegenerative diseases. These events include the signing of exclusive partnership agreements with global pharmaceutical leaders, such as Takeda, for the development of active immunotherapies targeting Alzheimer's disease. Additionally, receiving the FDA fast track designation for their ACI-24.060 therapy indicates regulatory recognition of their novel approach. These events underscore AC Immune's commitment to advancing precision medicine and innovative treatments for neurodegeneration.
-
Active
Health Care/Life Sciences
EPFL Innovation Park Building B Lausanne Vaud 1015 Switzerland...
Switzerland
161
Monica Shaw (Independent Non-Executive Director)
Christopher Roberts (Chief Financial Officer & Vice President)
Piergiorgio Donati (Chief Technical Operations Officer)
16.47 M
$3.07
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDCAiDOOS Information Wiki provides comprehensive information about products, companies, and individuals.
-
Health Care/Life Sciences
EPFL Innovation Park Building B Lausanne Vaud 1015 Switzerland...
Switzerland
161+
16.47 M
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.
The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC